Robert S Bresalier Selected Research

Adenocarcinoma

7/2023	Sperm protein antigen 17 and Sperm flagellar 1 cancer testis antigens are expressed in a rare case of ciliated foregut cyst of the common hepatic duct.
1/2019	Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study.
1/2018	Chemoprevention of Barrett's Esophagus and Esophageal Adenocarcinoma.
1/2018	Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
1/2018	Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
11/2016	Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics.
6/2011	Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.
1/2009	Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.
11/2007	COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma.
12/2005	Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert S Bresalier Research Topics

Disease

40	Neoplasms (Cancer) 10/2023 - 11/2003
39	Adenoma (Adenomas) 01/2021 - 01/2004
15	Polyps 10/2019 - 03/2005
13	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2002
11	Adenocarcinoma 07/2023 - 01/2004
8	Colonic Neoplasms (Colon Cancer) 06/2013 - 09/2002
7	Carcinogenesis 05/2017 - 04/2005
6	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 08/2008
6	Carcinoma (Carcinomatosis) 07/2023 - 04/2005
6	Breast Neoplasms (Breast Cancer) 07/2023 - 05/2004
4	Inflammation (Inflammations) 01/2023 - 11/2007
4	Barrett Esophagus (Barrett's Esophagus) 01/2018 - 04/2004
4	Adenomatous Polyps 04/2012 - 09/2004
4	Ovarian Neoplasms (Ovarian Cancer) 09/2010 - 11/2004
4	Neoplasm Metastasis (Metastasis) 12/2005 - 09/2002
3	Colitis 01/2019 - 12/2008
2	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 10/2020
2	Testicular Neoplasms (Testicular Cancer) 07/2023 - 09/2017
2	Stomach Neoplasms (Stomach Cancer) 07/2022 - 05/2014
2	Metaplasia 01/2018 - 05/2017
2	Hemorrhage 01/2018 - 12/2008
2	Esophagitis 01/2018 - 12/2008
2	Diarrhea 01/2017 - 12/2008
2	Nausea 12/2015 - 12/2008
2	Microsatellite Instability 04/2012 - 01/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2023
1	Cholangiocarcinoma 07/2023
1	Endometrial Neoplasms (Endometrial Cancer) 07/2023
1	Cysts 07/2023
1	COVID-19 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Fibrosis (Cirrhosis) 10/2020
1	Gastritis 05/2019
1	Overweight 01/2019
1	Hemorrhagic Stroke 01/2018
1	Ulcer 01/2018

Drug/Important Bio-Agent (IBA)

16	Galectin 3 (LGALS3)IBA 01/2018 - 09/2002
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 11/2003
11	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019 - 06/2007
9	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2004
9	Vitamin D FDA LinkGeneric 01/2023 - 01/2006
9	MucinsIBA 04/2022 - 08/2002
9	CalciumIBA 01/2019 - 11/2004
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 06/2006
7	Cholecalciferol (Vitamin D3)FDA Link 01/2019 - 01/2006
6	Carrier Proteins (Binding Protein)IBA 01/2018 - 09/2002
5	LigandsIBA 10/2011 - 09/2002
4	Cyclin D1IBA 01/2021 - 12/2005
4	beta-galactosideIBA 12/2005 - 09/2002
3	AntibodiesIBA 07/2023 - 01/2004
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2023 - 05/2017
3	Immune Checkpoint InhibitorsIBA 05/2019 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011 - 07/2007
3	rofecoxib (Vioxx)FDA Link 11/2008 - 03/2005
2	AntigensIBA 07/2023 - 09/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2023 - 01/2004
2	HaptoglobinsIBA 01/2021 - 09/2004
2	ChemokinesIBA 01/2021 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 02/2009
2	hydroxide ionIBA 11/2016 - 10/2014
2	Galectins (Galectin)IBA 01/2016 - 07/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 10/2011
2	polyphenon EIBA 12/2015 - 01/2009
2	TeaIBA 12/2015 - 01/2009
2	25-hydroxyvitamin DIBA 10/2014 - 11/2013
2	EnzymesIBA 01/2013 - 02/2006
2	Small Interfering RNA (siRNA)IBA 01/2012 - 02/2009
2	Lipocalin-2IBA 06/2011 - 08/2008
2	Complementary DNA (cDNA)IBA 02/2009 - 11/2005
2	Bile Acids and Salts (Bile Acids)IBA 11/2007 - 04/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2006 - 03/2005
2	SmokeIBA 02/2006 - 06/2005
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2005 - 04/2005
2	Glycoproteins (Glycoprotein)IBA 09/2004 - 01/2004
1	sotorasibIBA 10/2023
1	KRASG12D inhibitor MRTX1133IBA 10/2023
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	Oncogene Proteins (Oncogene Protein)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 07/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	AdiponectinIBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Formaldehyde (Formol)FDA Link 01/2019
1	SteroidsIBA 01/2019
1	ParaffinIBA 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	vedolizumabIBA 01/2019
1	CytokinesIBA 01/2018

Therapy/Procedure

20	Chemoprevention 01/2023 - 01/2002
9	Therapeutics 10/2023 - 12/2008
5	Drug Therapy (Chemotherapy) 05/2019 - 12/2008
3	Immunotherapy 05/2021 - 09/2017
3	Radiotherapy 05/2019 - 12/2008
2	Colonoscopes 06/2013 - 03/2010
2	Molecular Targeted Therapy 09/2010 - 12/2008
2	Chemoradiotherapy 02/2006 - 10/2005